Photo of William J. Martin, president of the Lisa Dean Moseley Foundation
Nemours Children’s Health announced a $78 million donation from the Lisa Dean Moseley Foundation of Wilmington to fund new and innovative research programs and to expand Nemours Children’s capacity to provide clinical care for children with cancer, sickle cell disease, and other blood disorders.
The announcement was made in the unfinished, fifth-floor shell space at Nemours Children’s Hospital, near Wilmington that will become a new inpatient unit to be known as the Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders at Nemours Children’s Health.
“I would like to express profound gratitude from all of Nemours to the Moseley Foundation for this generous gift to Delaware’s children. The new Moseley Foundation Institute will positively influence pediatric cancer and blood disorder care worldwide,” said Nemours Children’s Health CEO R. Lawrence Moss, MD. “Philanthropy of this magnitude allows us to transform our ability to improve the lives of children with cancer and blood disorders such as sickle cell disease. This gift will help us to provide better care and patient experience today, to conduct research that will improve tomorrow’s care, and to take concrete actions to ensure every child receives optimal care regardless of race or economic circumstances.”
“We are proud to partner with Nemours Children’s Health to champion innovative research and clinical care for kids with cancer and blood disorders,” said William J. Martin, Esq., president of the Lisa Dean Moseley Foundation. “Every child deserves the brightest future possible, and we are honored that Lisa’s legacy will allow Nemours to continue to make a profound impact on the children in Delaware and throughout the region, and in particular to help patients with diseases that have been long overlooked and underfunded, such as those afflicted with sickle cell disease.”
The $78 million gift, payable over 10 years, will allow Nemours to further its capabilities and services to support and improve the health of Delaware’s children, which is aligned with Alfred I. duPont’s philanthropic vision and the funding of the Alfred I. duPont Charitable Trust.
Every dollar of the $78 million donation will be used to make immediate and long-term impacts on pediatric cancer and blood disorder treatment and research. The new initiatives include:
“Progress in the care and outcomes for children with cancer and blood disorders has been dependent on innovative research,” said Edward Anders Kolb, MD, director of the Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders at Nemours Children’s Health. “Nemours is committed to developing new treatment options to promote better outcomes for pediatric patients and their families. This momentous gift will allow Nemours to further improve our facility and bring together the best and brightest minds dedicated to this cause.”
Nemours Children’s Health is one of the nation’s largest multistate pediatric health systems, which includes two free-standing children’s hospitals and a network of more than 70 primary and specialty care practices.
The Nemours Foundation, established through the legacy and philanthropy of Alfred I. duPont, provides pediatric clinical care, research, education, advocacy, and prevention programs to the children, families and communities. More information is available at Nemours.org.
The foundation had been in an uneasy relationship with Delaware officials who filed suit, claiming the organization was not living up to duPont’s wishes by putting too many resources into its Florida operations. A settlement was later reached.
Alfred duPont left Delaware and DuPont for Florida, where he built a business empire that included extensive land holdings, a railroad and a paper company that funded the trust.
Based in Wilmington, the Lisa Dean Moseley Foundation is a non-profit organization that supports basic medical and scientific research. The Foundation collaborates with organizations such as Nemours Children’s Health, the American Cancer Society, the Helen Graham Cancer Center, and the Cleveland Clinic others.
Lisa Mosley, who died in 2016, was a DuPont family heiress who resided in Delaware and New York. Before her death, Mosley set up a foundation that focuses on medical research.
